The association between COX-2 overexpression and unfavorable prognosis has later extended to various cancer types including melanoma [208], breast [209], prostate [210, 211], laryngeal [212], esophageal [213], gastric [214], pancreatic [215], and ovarian cancer [216]. This evidence concerns the gene PTGS2 and cancer.